﻿<?xml version="1.0" encoding="utf-8"?>
<APML>
  <Head>
    <Title>APML data for Pharmanet - Blog</Title>
    <Generator>BlogEngine.NET 1.6.0.0</Generator>
    <UserEmail />
    <DateCreated>2/21/2012 9:42:42 PM</DateCreated>
  </Head>
  <Body defaultProfile="tags">
    <Profile name="tags">
      <ImplicitData>
        <Concepts>
          <Concept key="drug development" value="1" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="adjuvants" value="0.75" from="http://blog.pharmanet.com/" updated="10/5/2010 5:23:42 AM" />
          <Concept key="vaccine" value="0.75" from="http://blog.pharmanet.com/" updated="10/5/2010 5:23:42 AM" />
          <Concept key="Phase I" value="0.75" from="http://blog.pharmanet.com/" updated="9/28/2011 10:31:21 AM" />
          <Concept key="pathogens" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="DNA" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="MABEL" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="RNA" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="HSN1" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="adaptive designs" value="0.5" from="http://blog.pharmanet.com/" updated="3/4/2011 11:17:30 AM" />
          <Concept key="FIH" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="first in human" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="MAD" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="SAD" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="data" value="0.5" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="pharmacodynamics" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="minimum anticipated biological effect level" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="pharmacokinetics" value="0.5" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="observational research" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="cost-effectiveness studies" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="quality of life" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="risk management" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="comparative effectiveness research" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="expanded access studies" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="CER" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="REMS" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="post-approval" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="viruses" value="0.5" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="biosimilars" value="0.5" from="http://blog.pharmanet.com/" updated="9/28/2011 10:31:21 AM" />
          <Concept key="clinical research" value="0.25" from="http://blog.pharmanet.com/" updated="10/4/2010 9:25:44 AM" />
          <Concept key="adaptive trial design" value="0.25" from="http://blog.pharmanet.com/" updated="10/4/2010 9:25:44 AM" />
          <Concept key="data monitoring" value="0.25" from="http://blog.pharmanet.com/" updated="10/4/2010 9:25:44 AM" />
          <Concept key="antiepileptic" value="0.25" from="http://blog.pharmanet.com/" updated="9/2/2010 10:04:23 AM" />
          <Concept key="epidemiology" value="0.25" from="http://blog.pharmanet.com/" updated="6/15/2010 11:39:08 AM" />
          <Concept key="clinical development" value="0.25" from="http://blog.pharmanet.com/" updated="10/4/2010 9:25:44 AM" />
          <Concept key="interim analysis" value="0.25" from="http://blog.pharmanet.com/" updated="10/4/2010 9:25:44 AM" />
          <Concept key="registries" value="0.25" from="http://blog.pharmanet.com/" updated="6/15/2010 11:39:08 AM" />
          <Concept key="outcome research" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="registeries" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="outcomes research" value="0.25" from="http://blog.pharmanet.com/" updated="6/15/2010 11:39:08 AM" />
          <Concept key="cardiac" value="0.25" from="http://blog.pharmanet.com/" updated="10/21/2010 11:25:47 AM" />
          <Concept key="QT" value="0.25" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="cardiac safety" value="0.25" from="http://blog.pharmanet.com/" updated="11/16/2010 10:05:17 AM" />
          <Concept key="epilepsy" value="0.25" from="http://blog.pharmanet.com/" updated="9/2/2010 10:04:23 AM" />
          <Concept key="autoimmune" value="0.25" from="http://blog.pharmanet.com/" updated="10/5/2010 5:23:42 AM" />
          <Concept key="biologicals" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="epidemology" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="pandemic" value="0.25" from="http://blog.pharmanet.com/" updated="10/5/2010 5:23:42 AM" />
          <Concept key="biologics" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="follow-on biologics" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="biotechnology" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="biogenerics" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="follow-on proteins" value="0.25" from="http://blog.pharmanet.com/" updated="7/15/2010 1:11:18 PM" />
          <Concept key="neuropsychological" value="0.25" from="http://blog.pharmanet.com/" updated="9/2/2010 10:04:23 AM" />
          <Concept key="cell therapies" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="neurological" value="0.25" from="http://blog.pharmanet.com/" updated="9/2/2010 10:04:23 AM" />
          <Concept key="children with epilepsy" value="0.25" from="http://blog.pharmanet.com/" updated="9/2/2010 10:04:23 AM" />
          <Concept key="stem cells" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="autologous" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="allogeneic" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="dendritic cells" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="immune cells" value="0.25" from="http://blog.pharmanet.com/" updated="8/13/2010 9:13:18 AM" />
          <Concept key="data collection" value="0.25" from="http://blog.pharmanet.com/" updated="8/16/2011 10:41:13 AM" />
          <Concept key="patient compliance" value="0.25" from="http://blog.pharmanet.com/" updated="8/16/2011 10:41:13 AM" />
          <Concept key="patient participation" value="0.25" from="http://blog.pharmanet.com/" updated="8/16/2011 10:41:13 AM" />
          <Concept key="pharmacodynamic" value="0.25" from="http://blog.pharmanet.com/" updated="9/28/2011 10:31:21 AM" />
          <Concept key="PK/PD" value="0.25" from="http://blog.pharmanet.com/" updated="9/28/2011 10:31:21 AM" />
          <Concept key="observational studies" value="0.25" from="http://blog.pharmanet.com/" updated="8/16/2011 10:41:13 AM" />
          <Concept key="EU Voluntary Harmonization Procedure" value="0.25" from="http://blog.pharmanet.com/" updated="7/11/2011 9:51:21 AM" />
          <Concept key="mAbs" value="0.25" from="http://blog.pharmanet.com/" updated="6/17/2011 11:59:20 AM" />
          <Concept key="surrogate endpoints" value="0.25" from="http://blog.pharmanet.com/" updated="6/17/2011 11:59:20 AM" />
          <Concept key="novel trial design" value="0.25" from="http://blog.pharmanet.com/" updated="6/17/2011 11:59:20 AM" />
          <Concept key="VHP" value="0.25" from="http://blog.pharmanet.com/" updated="7/11/2011 9:51:21 AM" />
          <Concept key="Clinical Trials" value="0.25" from="http://blog.pharmanet.com/" updated="7/11/2011 9:51:21 AM" />
          <Concept key="monoclonal antibodies" value="0.25" from="http://blog.pharmanet.com/" updated="6/17/2011 11:59:20 AM" />
          <Concept key="ePRO" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:53:52 PM" />
          <Concept key="electronic patient reported outcomes" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:53:52 PM" />
          <Concept key="quality" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:38:05 PM" />
          <Concept key="Mobile" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:53:52 PM" />
          <Concept key="IRT" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:53:52 PM" />
          <Concept key="smartphones" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:53:52 PM" />
          <Concept key="quality system" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:38:05 PM" />
          <Concept key="Affordable Care Act" value="0.25" from="http://blog.pharmanet.com/" updated="12/8/2011 3:59:40 PM" />
          <Concept key="placebo comparisonviruses" value="0.25" from="http://blog.pharmanet.com/" updated="12/8/2011 3:59:40 PM" />
          <Concept key="pharmacokinetic" value="0.25" from="http://blog.pharmanet.com/" updated="9/28/2011 10:31:21 AM" />
          <Concept key="Grip/Build/Engage" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:38:05 PM" />
          <Concept key="GBE" value="0.25" from="http://blog.pharmanet.com/" updated="12/9/2011 3:38:05 PM" />
          <Concept key="Comparitive Effectiveness Research" value="0.25" from="http://blog.pharmanet.com/" updated="12/8/2011 3:59:40 PM" />
          <Concept key="Study quality plan" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="Six Sigma" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="Lean Six Sigma" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="interactive trial design" value="0.25" from="http://blog.pharmanet.com/" updated="3/4/2011 11:17:30 AM" />
          <Concept key="Quality Assurance" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="Quality Control" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="clinical data" value="0.25" from="http://blog.pharmanet.com/" updated="2/22/2011 4:32:33 PM" />
          <Concept key="ICH M3" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="explorative design" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="conventional design" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="Preclinical" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="Clinical" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="ICH" value="0.25" from="http://blog.pharmanet.com/" updated="11/15/2010 7:14:40 PM" />
          <Concept key="partners" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="post marketing studies" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="product innovation" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="Biopharmaceutical companies" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="financial pressures" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="recession" value="0.25" from="http://blog.pharmanet.com/" updated="4/11/2011 11:52:11 AM" />
          <Concept key="woman" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
          <Concept key="female" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
          <Concept key="family" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
          <Concept key="Adaptive trial design" value="0.25" from="http://blog.pharmanet.com/" updated="3/4/2011 11:17:30 AM" />
          <Concept key="underrepresentation in clinical trials" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
          <Concept key="pregnancy" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
          <Concept key="childcare" value="0.25" from="http://blog.pharmanet.com/" updated="4/4/2011 12:07:00 PM" />
        </Concepts>
      </ImplicitData>
    </Profile>
    <Profile name="links">
      <ExplicitData>
        <Concepts>
          <Source key="http://www.madskristensen.dk/" name="Mads Kristensen" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="Mads Kristensen" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
          <Source key="http://www.nyveldt.com/blog/" name="Al Nyveldt" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="Al Nyveldt" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
          <Source key="http://rtur.net/blog/" name="Ruslan Tur" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="Ruslan Tur" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
          <Source key="http://johndyer.name/" name="John Dyer" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="John Dyer" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
          <Source key="http://blog.ruski.co.za/" name="Russell van der Walt" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="Russell van der Walt" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
          <Source key="http://allben.net/" name="Ben Amada" value="1.0" type="text/html" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM">
            <Author key="Ben Amada" value="1.0" from="http://blog.pharmanet.com/" updated="2/21/2012 9:42:42 PM" />
          </Source>
        </Concepts>
      </ExplicitData>
    </Profile>
  </Body>
</APML>
